undamentalytics Newsletter

Broadwood Partners, L.P.: insider trades

Director, 10% owner at 3 companies we cover. 27 open-market purchases and 2 sales not made under a pre-set plan, reported from April 22, 2011 to April 27, 2026.

Would copying Broadwood Partners, L.P.’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 12 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on April 25, 2011 into $38,794 by November 2, 2026, +9.2% a year. The copy held shares only 42% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $37,991, +9.0% a year (the S&P 500 held throughout made $74,251, +13.8% a year). Beta against the index was 0.46. Twelve months after each report, the average purchase was +24.2% against the S&P 500 (median +33.8%), and 75% beat it. Measured from the trade date, the insider’s own timing, the average was +16.9%. After their sales, the shares moved −50.4% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$50.0k$100k 20112013201520172019202120232025 $74.3k$38.8k$38.0k
Copying Broadwood Partners, L.P.S&P 500, same days investedS&P 500, held throughout $10,000 copying Broadwood Partners, L.P.’s open-market purchases from April 25, 2011, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+9.2%
S&P 500, same days invested
+9.0% (held throughout +13.8%)
Time in shares
42%
Sharpe ratio (S&P 500)
0.37 (0.75)
Biggest drop (S&P 500)
−76% (−34%)
Market sensitivity (beta)
0.46
Purchases copied
12

Trade by trade

Broadwood Partners, L.P.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 12 +6.0% +2.5% 67% 7 0.97 0.37 No reliable evidence
Purchases, 6 months after the report 12 +12.4% +6.8% 50% 7 1.50 0.18 No reliable evidence
Purchases, 12 months after the report 12 +24.2% +33.8% 75% 7 0.80 0.46 No reliable evidence
Purchases, 12 months after the trade 11 +16.9% +19.8% 64% 6 0.47 0.66 No reliable evidence
Sales, 3 months after the report 2 −5.3% −5.3% 100% 1 — — Not enough years
Sales, 12 months after the report 2 −50.4% −50.4% 100% 1 — — Not enough years
Sales, 12 months after the trade 2 −50.8% −50.8% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Staar Surgical Co STAA —122April 22, 2011April 7, 2025
Lineage Cell Therapeutics, Inc. LCTX —80November 19, 2012February 8, 2024
Insight Molecular Diagnostics Inc. IMDX —70July 2, 2019April 27, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
April 27, 2026April 23, 2026 IMDX Purchase $2,031,940 not yetnot yetnot yet
April 7, 2025April 3, 2025 STAA Purchase $13,626,459 −8.4%+36.8%−3.0%
April 2, 2025March 31, 2025 STAA Purchase $941,345 −20.5%−3.0%−8.8%
February 10, 2025February 6, 2025 IMDX Purchase $10,589,675 not yetnot yetnot yet
April 15, 2024April 11, 2024 IMDX Purchase $7,066,400 not yetnot yetnot yet
February 8, 2024February 6, 2024 LCTX Purchase $7,000,001 not yetnot yetnot yet
January 5, 2024January 3, 2024 STAA Purchase $6,482,425 +54.9%−53.0%−43.9%
April 5, 2023April 3, 2023 IMDX Purchase $8,048,291 not yetnot yetnot yet
December 29, 2022December 27, 2022 STAA Purchase $9,062,185 +21.6%−64.3%−60.0%
April 15, 2022April 14, 2022 IMDX Purchase $7,984,990 not yetnot yetnot yet
June 15, 2021June 11, 2021 STAA Sale $8,787,536 −10.4%−47.4%−47.5%
June 1, 2021May 27, 2021 STAA Sale $39,065,521 −0.3%−53.3%−54.1%
September 13, 2019September 11, 2019 IMDX Purchase $3,320,000 not yetnot yetnot yet
July 2, 2019July 2, 2019 IMDX Purchase $2,000,000 not yetnot yetnot yet
August 2, 2017July 31, 2017 LCTX Purchase $420,000 not yetnot yetnot yet
February 17, 2017February 15, 2017 LCTX Purchase $5,999,999 not yetnot yetnot yet
June 23, 2016June 21, 2016 LCTX Purchase $6,531,000 not yetnot yetnot yet
February 4, 2016February 2, 2016 STAA Purchase $779,066 +8.6%+36.8%+38.1%
February 1, 2016January 28, 2016 STAA Purchase $427,835 +11.2%+38.1%+30.9%
January 27, 2016January 25, 2016 STAA Purchase $1,585,826 +8.4%+30.9%+19.8%
January 22, 2016January 20, 2016 LCTX Purchase $705,000 not yetnot yetnot yet
January 21, 2016January 19, 2016 STAA Purchase $491,652 +2.8%+17.6%+23.6%
January 4, 2016December 30, 2015 STAA Purchase $1,175,840 +2.2%+37.7%+42.3%
August 25, 2015August 21, 2015 STAA Purchase $1,353,959 +1.4%0.0%+14.2%
July 24, 2014July 22, 2014 LCTX Purchase $980,500 not yetnot yetnot yet
February 27, 2014February 25, 2014 LCTX Purchase $1,870,000 not yetnot yetnot yet
November 19, 2012November 15, 2012 STAA Purchase $13,090 −4.5%+117.3%+133.1%
November 19, 2012November 15, 2012 LCTX Purchase $1,000,001 not yetnot yetnot yet
April 22, 2011April 20, 2011 STAA Purchase $102,150 −5.4%+95.5%not yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Broadwood Partners, L.P. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.